Vatnikas
评论了
$BioVie(BIVI.US$
NEWS
BioVie to Present Data Showing How NE3107 Potentially Restores Homeostasis via Specific Genes Associated with Dementia, Metabolism, and Inflammation Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags conferences Rhea-AI Summary BioVie Inc. (Nasdaq: BIVI) announced the approval of the non-proprietary name 'bezisterim' for NE3107, a potential treatment for neurological disorders. The company will present data at the 12th Annual Alzheimer's & Parkinson's Drug Development S...
NEWS
BioVie to Present Data Showing How NE3107 Potentially Restores Homeostasis via Specific Genes Associated with Dementia, Metabolism, and Inflammation Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags conferences Rhea-AI Summary BioVie Inc. (Nasdaq: BIVI) announced the approval of the non-proprietary name 'bezisterim' for NE3107, a potential treatment for neurological disorders. The company will present data at the 12th Annual Alzheimer's & Parkinson's Drug Development S...
1
2
Vatnikas
留下了心情
$BioVie(BIVI.US$ BIV201 第三阶段正在等待来自 “尚未公开的合作伙伴” 的资金,合作伙伴拖延了脚步,并不急于削减应付的经济、新冠肺炎和乌克兰牛市。特别是如果那个尚未公开的合作伙伴想收购Biovie,因此有兴趣以低价购买BIVI的股票。
好消息将在 “2024 年夏季中旬” 或更早出现,届时将宣布合作伙伴关系和 BIV201 第 3 阶段资金
好消息将在 “2024 年夏季中旬” 或更早出现,届时将宣布合作伙伴关系和 BIV201 第 3 阶段资金
已翻译
4
Vatnikas
评论了
$BioVie(BIVI.US$ 持有 @ 1.3。下一次 PR 是什么时候?说真的,它处于可悲的状态...
已翻译
6
Vatnikas Aman dhillon : 你得等新闻稿